Amitabha Ray, M.B.B.S., MS, MD, PhD

Amitabha Ray completed his graduation in Medicine (MBBS) from the University of Calcutta, subsequently residency in Pathology, his medical postgraduate degree (M.D.) at the Banaras Hindu University, Varanasi, and his Ph.D. from J.M.I., New Delhi, India. He was associated with the Indian Council of Medical Research. He pursued his postdoctoral research in Professor Margot P. Cleary’s laboratory at the Hormel Institute (University of Minnesota), Austin, MN. In Dr. Cleary’s lab, he worked primarily on the role of obesity and the interactions between different adipocyte-released cytokines, particularly leptin and adiponectin in breast cancer pathology. In recent times, he completed the Master of Science program in Medical Education from the Lake Erie College of Osteopathic Medicine, Pennsylvania, and a one-year Postgraduate Certificate program in Clinical Microbiology & Infectious Diseases from the University of Edinburgh, United Kingdom. He has published more than 70 scientific papers in different journals, mainly on cancer. For about 13 years, he has continuously taught basic science subjects, including Pathology, to medical/health science students.

• Ph.D. in Cancer Biology, J.M.I. University (New Delhi, India), 2002
• M.D. in Clinical Biochemistry, Banaras Hindu University (Varanasi, India), 1990
• M.B.B.S. (Bachelor of Medicine & Bachelor of Surgery), University of Calcutta (India), 1986
• M.S. in Medical Education, Lake Erie College of Osteopathic Medicine (Pennsylvania), 2020
• Postgraduate Certificate in Clinical Microbiology and Infectious Diseases, University of Edinburgh (U.K.), 2022

• Adipose tissue-released cytokines (adipokines) in hormone-dependent cancers
• Excess body weight as a risk factor for diseases such as type-2 diabetes, hypertension, and other cardiovascular disorders.
• Impact of overweight or obesity on cancer prognosis
• Pathological processes of chronic/persistent viral diseases

• Ray A, Moore TF, Naik DSL and Borsch DM. Insights into the two most common cancers of primitive gut-derived structures and their microbial connections. Medicina (Kaunas) 2024, 60(9), 1515; doi: 10.3390/medicina60091515.
• Ray A, Moore TF, Pandit R, Burke AD and Borsch DM. An overview of selected bacterial infections in cancer, their virulence factors, and some aspects of infection management. Biology (Basel) 2023; 12(7): 963. doi: 10.3390/biology12070963.
• Ray A, Winter KAK, Naik DSL and Okorie C. Prognostic significance of the coagulation and complement systems in critical COVID-19 infection. Prague Med Rep 2023; 124(2): 77-93. doi: 10.14712/23362936.2023.7.
• Ray A, Bonorden MJL, Pandit R, Nkhata KJ and Bishayee A. Infections and immunity: associations with obesity and related metabolic disorders. J Pathol Transl Med 2023; 57(1): 28-42. doi: 10.4132/jptm.2022.11.14.
• Burke AD, Burns JW, Chakraborty S, Saha T, Ray A and Borsch DM. Evaluation of cancer awareness, cancer education levels, and prevention intervention techniques among university-level students in the United States and India. J Educ Health Promot 2022; 11: 187. doi: 10.4103/jehp.jehp_1422_21.
• Ray A and Acharya D. Adiponectin-enhancing dietary constituents in cancer prevention. In, Functional Foods in Cancer Prevention and Therapy (Editor: Y. Kabir). Academic Press – Elsevier, London; pp. 73-98, 2020.
• Ray A. Cancer and comorbidity: The role of leptin in breast cancer and associated pathologies. World J Clin Cases 2018; 6(12): 483-92. doi: 10.12998/wjcc.v6.i12.483.
• Ray A, Fornsaglio J, Dogan S, Hedau S, Naik D and De A. Gynaecological cancers and leptin: A focus on the endometrium and ovary. Facts Views Vis Obgyn 2018;10(1): 5-18.
• Ray A. Tumor-linked HER2 expression: association with obesity and lipid-related microenvironment. Horm Mol Biol Clin Investig 2017; 32(3): 20170020. doi: 10.1515/hmbci-2017-0020.
• Ray A and Cleary MP. The potential role of leptin in tumor invasion and metastasis. Cytokine Growth Factor Rev 2017; 38: 80-97. doi: 10.1016/j.cytogfr.2017.11.002.